A patient who is on treatment for hyperlipidemia develops gallstones. What is the mechanism of action of the causative drug that was given to this patient?
ABinds to deoxycholic acid
BDecreases VLDL
CActivates PPAR alpha
DInhibits HMG CoA reductase
Which of the following is not a risk factor for cholangiocarcinoma?
AThorotrast
BRadon
CDioxin
DAflatoxin
Which of the following substances is NOT typically found in gallstones?
ACholesterol
BOxalates
CPhosphate
DCarbonate
+ 7 more in the PDF
Browse all chapters